Michael Thomas Heffernan - 25 Mar 2025 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AVTX	Stock Option (Right to Buy)	Award	$0	+50,000		$0.000000	50,000	25 Mar 2025	Common Stock	50,000	$8.54	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock option vests in three substantially equal annual installments on the first, second and third anniversary of the date of grant, subject to the Eligible Director's continued service on each such vesting date.